Lactobacillus and Bifidobacterium species have been shown to reduce inflammatory responses, including NF-κB activation and IL-8 production, in inflammatory IECs, rodent colitis models and patients with IBD [9,16]. This evidence concerns the gene NFKB1 and colitis.